Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Apellis Pharmaceuticals (APLS) over the last 5 years, with Sep 2025 value amounting to 1.08.

  • Apellis Pharmaceuticals' Asset Utilization Ratio rose 36.53% to 1.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.08, marking a year-over-year increase of 36.53%. This contributed to the annual value of 0.93 for FY2024, which is 82.33% up from last year.
  • As of Q3 2025, Apellis Pharmaceuticals' Asset Utilization Ratio stood at 1.08, which was up 16.67% from 0.93 recorded in Q2 2025.
  • In the past 5 years, Apellis Pharmaceuticals' Asset Utilization Ratio registered a high of 1.08 during Q3 2025, and its lowest value of 0.08 during Q1 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.72 (2024), whereas its average is 0.64.
  • In the last 5 years, Apellis Pharmaceuticals' Asset Utilization Ratio plummeted by 72.51% in 2022 and then surged by 434.39% in 2023.
  • Quarterly analysis of 5 years shows Apellis Pharmaceuticals' Asset Utilization Ratio stood at 0.09 in 2021, then climbed by 4.19% to 0.09 in 2022, then soared by 434.39% to 0.49 in 2023, then surged by 77.18% to 0.87 in 2024, then skyrocketed by 36.53% to 1.08 in 2025.
  • Its Asset Utilization Ratio was 1.08 in Q3 2025, compared to 0.93 in Q2 2025 and 0.92 in Q1 2025.